The metastatic niche: adapting the foreign soil - Nature Reviews Cancer
- ️Lyden, David
- ️Wed Apr 01 2009
Paget, S. The distribution of secondary growths in cancer of the breast. Lancet 1, 571–573 (1889).
Paget, S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 8, 98–101 (1989).
Virchow, R. Cellularpathologie 1st edn (ed. Hirschwalkd, A.) (Berlin, 1858).
Ewing, J. Neoplastic diseases 6th edn (ed. Saunders, W.) (W. B. Saunders Co., Philadelphia, 1928).
Fidler, I. J. & Kripke, M. L. Metastasis results from preexisting variant cells within a malignant tumor. Science 197, 893–895 (1977).
Hart, I. R. & Fidler, I. J. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Res. 40, 2281–2287 (1980).
Li, L. & Neaves, W. B. Normal stem cells and cancer stem cells: the niche matters. Cancer Res. 66, 4553–4557 (2006).
Yin, T. & Li, L. The stem cell niches in bone. J. Clin. Invest. 116, 1195–1201 (2006).
Zhang, J. & Li, L. Stem cell niche: microenvironment and beyond. J. Biol. Chem. 283, 9499–9503 (2008).
Scadden, D. T. The stem-cell niche as an entity of action. Nature 441, 1075–1079 (2006).
Sneddon, J. B. & Werb, Z. Location, location, location: the cancer stem cell niche. Cell Stem Cell 1, 607–611 (2007).
Psaila, B., Kaplan, R. N., Port, E. R. & Lyden, D. Priming the 'soil' for breast cancer metastasis: the pre-metastatic niche. Breast Dis. 26, 65–74 (2006).
Folkman, J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29, 15–18 (2002).
Weigelt, B. & Bissell, M. J. Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin. Cancer Biol. 18, 311–321 (2008).
Joyce, J. A. & Hanahan, D. Multiple roles for cysteine cathepsins in cancer. Cell Cycle 3, 1516–1619 (2004).
Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436–444 (2008).
Chambers, A. F., Groom, A. C. & MacDonald, I. C. Dissemination and growth of cancer cells in metastatic sites. Nature Rev. Cancer 2, 563–572 (2002).
Weiss, L. & Ward, P. M. Arrest and retention of circulating cancer cells in the lungs of animals with defined metastatic status. Cancer Res. 42, 1898–1903 (1982).
Kaplan, R. N. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438, 820–827 (2005).
Weiss, L., Mayhew, E., Rapp, D. G. & Holmes, J. C. Metastatic inefficiency in mice bearing B16 melanomas. Br. J. Cancer 45, 44–53 (1982).
Hiratsuka, S., Watanabe, A., Aburatani, H. & Maru, Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nature Cell Biol. 8, 1369–1375 (2006).
Hiratsuka, S. et al. The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase. Nature Cell Biol. 10, 1349–1355 (2008).
Wels, J., Kaplan, R. N., Rafii, S. & Lyden, D. Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev. 22, 559–574 (2008).
Peinado, H., Rafii, S. & Lyden, D. Inflammation joins the “niche”. Cancer Cell 14, 347–349 (2008).
Lyden, D. et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Med. 7, 1194–1201 (2001).
Karnoub, A. E. et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557–563 (2007).
Nilsson, S. K., Johnston, H. M. & Coverdale, J. A. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 97, 2293–2299 (2001).
Calvi, L. M. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841–846 (2003).
Kiel, M. J., Yilmaz, O. H., Iwashita, T., Terhorst, C. & Morrison, S. J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121, 1109–1121 (2005).
Kiel, M. J. & Morrison, S. J. Uncertainty in the niches that maintain haematopoietic stem cells. Nature Rev. Immunol. 8, 290–301 (2008).
Kaplan, R. N., Psaila, B. & Lyden, D. Niche-to-niche migration of bone-marrow-derived cells. Trends Mol. Med. 13, 72–81 (2007).
Alix-Panabieres, C., Riethdorf, S. & Pantel, K. Circulating tumor cells and bone marrow micrometastasis. Clin. Cancer Res. 14, 5013–5021 (2008).
Jones, D. H. et al. Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440, 692–696 (2006).
Mantovani, A. Cancer: Inflaming metastasis. Nature 457, 36–37 (2009).
Giavazzi, R. et al. Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res. 50, 4771–4775 (1990).
Kim, S. et al. Carcinoma produced factors activate myeloid cells via TLR2 to stimulate metastasis. Nature 457, 102–106 (2009).
Hiratsuka, S. et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2, 289–300 (2002).
Page-McCaw, A., Ewald, A. J. & Werb, Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nature Rev. Mol. Cell Biol. 8, 221–233 (2007).
Lopez-Otin, C. & Matrisian, L. M. Emerging roles of proteases in tumour suppression. Nature Rev. Cancer 7, 800–808 (2007).
Yang, L. & Moses, H. L. Transforming growth factor b: tumor suppressor or promoter? Are host immune cells the answer? Cancer Res. 68, 9107–9111 (2008).
Wai, P. Y. & Kuo, P. C. Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev. 27, 103–118 (2008).
Bellahcene, A., Castronovo, V., Ogbureke, K. U., Fisher, L. W. & Fedarko, N. S. Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nature Rev. Cancer 8, 212–226 (2008).
Pollard, J. W. Tumour-educated macrophages promote tumour progression and metastasis. Nature Rev. Cancer 4, 71–78 (2004).
Yang, L. et al. Abrogation of TGFb signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13, 23–35 (2008).
Lin, E. Y. & Pollard, J. W. Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res. 67, 5064–5066 (2007).
Jin, D. K. et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nature Med. 12, 557–567 (2006).
Italiano, J. E. Jr et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111, 1227–1233 (2008).
Rafii, D. C., Psaila, B., Butler, J., Jin, D. K. & Lyden, D. Regulation of vasculogenesis by platelet-mediated recruitment of bone marrow-derived cells. Arterioscler. Thromb. Vasc. Biol. 28, 217–222 (2008).
Jain, S. et al. Platelet glycoprotein Iba supports experimental lung metastasis. Proc. Natl Acad. Sci. USA 104, 9024–9028 (2007).
Kucia, M. et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1–CXCR4 axis. Stem Cells 23, 879–894 (2005).
Orimo, A. et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335–348 (2005).
Kalluri, R. & Zeisberg, M. Fibroblasts in cancer. Nature Rev. Cancer 6, 392–401 (2006).
Erler, J. T. et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow-derived cell recruitment to form the pre-metastatic niche. Cancer Cell 15, 35–44 (2009).
van Deventer, H. W. et al. C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9. Am. J. Pathol. 173, 253–264 (2008).
Erler, J. T. et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell 15, 35–44 (2009).
Cheng, J. D. & Weiner, L. M. Tumors and their microenvironments: tilling the soil. Commentary re: A. M. Scott. et al. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin. Cancer Res. 9, 1590–1595 (2003).
Olaso, E. et al. Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology 26, 634–642 (1997).
Olaso, E. et al. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis. Hepatology 37, 674–685 (2003).
Zeisberg, E. M., Potenta, S. E., Sugimoto, H., Zeisberg, M. & Kalluri, R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J. Am. Soc. Nephrol 19, 2282–2287 (2008).
Ghajar, C. M. & Bissell, M. J. Extracellular matrix control of mammary gland morphogenesis and tumorigenesis: insights from imaging. Histochem. Cell Biol. 130, 1105–1118 (2008).
Du, R. et al. HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13, 206–220 (2008).
Denko, N. C. et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22, 5907–5914 (2003).
Erler, J. T. et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440, 1222–1226 (2006).
Astrof, S. et al. Direct test of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor angiogenesis. Mol. Cell. Biol. 24, 8662–8670 (2004).
Alcaraz, J. et al. Laminin and biomimetic extracellular elasticity enhance functional differentiation in mammary epithelia. EMBO J. 27, 2829–2838 (2008).
McDonbald, D. M. & Baluk, P. Significance of blood vessel leakiness in cancer. Cancer Res, 62, 5381–5385 (2002).
Dvorak, H. F., Nagy, J. A., Dvorak, J. T. & Dvorak, A. M. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol. 133, 95–109 (1988).
Padua, D. et al. TGFβ primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133, 66–77 (2008).
Ribatti, D., Nico, B., Vacca, A., Roncali, L. & Dammacco, F. Endothelial cell heterogeneity and organ specificity. J. Hematother. Stem Cell Res. 11, 81–90 (2002).
LeCouter, J. et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412, 877–884 (2001).
LeCouter, J., Lin, R. & Ferrara, N. Endocrine gland-derived VEGF and the emerging hypothesis of organ-specific regulation of angiogenesis. Nature Med. 8, 913–917 (2002).
Minn, A. J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518–524 (2005).
Ding, L. et al. In vivo evaluation of the early events associated with liver metastasis of circulating cancer cells. Br. J. Cancer 85, 431–438 (2001).
Biancone, L., Araki, M., Araki, K., Vassalli, P. & Stamenkovic, I. Redirection of tumor metastasis by expression of E-selectin in vivo. J. Exp. Med. 183, 581–587 (1996).
Hirakawa, S. et al. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109, 1010–1017 (2007).
Hirakawa, S. et al. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J. Exp. Med. 201, 1089–1099 (2005).
Rinderknecht, M. & Detmar, M. Tumor lymphangiogenesis and melanoma metastasis. J. Cell Physiol. 216, 347–354 (2008).
Podsypanina, K. et al. Seeding and propagation of untransformed mouse mammary cells in the lung. Science 321, 1841–1844 (2008).
Chin, L. The genetics of malignant melanoma: lessons from mouse and man. Nature Rev. Cancer 3, 559–570 (2003).
Bidard, F. C., Pierga, J. Y., Vincent-Salomon, A. & Poupon, M. F. A “class action” against the microenvironment: do cancer cells cooperate in metastasis? Cancer Metastasis Rev. 27, 5–10 (2008).
Weiss, L. Metastatic inefficiency. Adv. Cancer Res. 54, 159–211 (1990).
Weiss, L. Cancer cell traffic from the lungs to the liver: an example of metastatic inefficiency. Int. J. Cancer 25, 385–392 (1980).
Langley, R. R. & Fidler, I. J. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr. Rev. 28, 297–321 (2007).
Minn., A. J. et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115, 44–55 (2005).
Minn., A. J. et al. Lung metastasis genes couple breast tumor size and metastatic spread. Proc. Natl Acad. Sci. USA 104, 6740–6745 (2007).
Lyden, D. et al. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401, 670–677 (1999).
Gupta, G. P. et al. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc. Natl Acad. Sci. USA 104, 19506–19511 (2007).
Steeg, P. S. Metastasis suppressors alter the signal transduction of cancer cells. Nature Rev. Cancer 3, 55–63 (2003).
Vaida, K. S. et al. Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling. J. Biol. Chem 283, 28354–28360 (2008).
Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645–648 (1994).
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983–3988 (2003).
Mani, S. A. et al. The epithelial–mesenchymal transition generates cells with properties of stem cells. Cell 133, 704–715 (2008).
Larizza, L. et al. Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage. Int. J. Cancer 34, 699–707 (1984).
Pawelek, J. M. & Chakraborty, A. K. The cancer cell–leukocyte fusion theory of metastasis. Adv. Cancer Res. 101, 397–444 (2008).
Pawelek, J. M. & Chakraborty, A. K. Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nature Rev. Cancer 8, 377–386 (2008).
Mehlen, P. & Puisieux, A. Metastasis: a question of life or death. Nature Rev. Cancer 6, 449–458 (2006).
Yu, Q., Toole, B. P. & Stamenkovic, I. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J. Exp. Med. 186, 1985–1996 (1997).
Holmgren, L., O'Reilly, M. S. & Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med. 1, 149–153 (1995).
Naumov, G. N., Akslen, L. A. & Folkman, J. Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 5, 1779–1787 (2006).
Gao, D. et al. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319, 195–198 (2008).
Yamamoto, M. et al. TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche. Cancer Res. 68, 9754–9762 (2008).
Wang, J. & Armant, D. R. Integrin-mediated adhesion and signaling during blastocyst implantation. Cells Tissues Organs 172, 190–201 (2002).
Wang, J., Mayernik, L. & Armant, D. R. Integrin signaling regulates blastocyst adhesion to fibronectin at implantation: intracellular calcium transients and vesicle trafficking in primary trophoblast cells. Dev. Biol. 245, 270–279 (2002).
Hess, R. A., Cooke, P. S., Hofmann, M. C. & Murphy, K. M. Mechanistic insights into the regulation of the spermatogonial stem cell niche. Cell Cycle 5, 1164–1170 (2006).
Taupin, P. Adult neural stem cells, neurogenic niches, and cellular therapy. Stem Cell Rev. 2, 213–219 (2006).
Steinman, L. Nuanced roles of cytokines in three major human brain disorders. J. Clin. Invest. 118, 3557–3563 (2008).
Libby, P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am. J. Med. 121, S21–S31 (2008).
Weber, C., Zernecke, A. & Libby, P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nature Rev. Immunol. 8, 802–815 (2008).
Szekanecz, Z. & Koch, A. E. Mechanisms of disease: angiogenesis in inflammatory diseases. Nature Clin. Pract. Rheumatol. 3, 635–643 (2007).